Sg Americas Securities, LLC Global Blood Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$32.4 - $68.18 $1.3 Million - $2.73 Million	-40,034 Reduced 82.19%	8,674 $591,000
Q2 2022 Jul 29, 2022	BUY	$22.3 - $37.39 $869,610 - $1.46 Million	38,996 Added 401.52%	48,708 $1.56 Million
Q1 2022 Apr 29, 2022	SELL	$25.68 - $35.59 $412,780 - $572,073	-16,074 Reduced 62.34%	9,712 $336,000
Q4 2021 Feb 07, 2022	SELL	$24.9 - $40.26 $394,366 - $637,637	-15,838 Reduced 38.05%	25,786 $755,000
Q3 2021 Nov 01, 2021	BUY	$25.48 - $37.34 $558,139 - $817,932	21,905 Added 111.09%	41,624 $1.06 Million
Q2 2021 Aug 12, 2021	BUY	$32.46 - $43.42 $334,500 - $447,443	10,305 Added 109.46%	19,719 $691,000
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $838,339 - $1.09 Million	-21,529 Reduced 69.58%	9,414 $384,000
Q4 2020 Feb 04, 2021	BUY	$37.65 - $63.77 $928,298 - $1.57 Million	24,656 Added 392.17%	30,943 $1.34 Million
Q3 2020 Nov 09, 2020	BUY	$52.76 - $74.49 $191,149 - $269,877	3,623 Added 136.0%	6,287 $347,000
Q2 2020 Jul 20, 2020	SELL	$48.73 - $81.82 $619,845 - $1.04 Million	-12,720 Reduced 82.68%	2,664 $168,000
Q1 2020 Apr 30, 2020	BUY	$41.72 - $87.2 $286,449 - $598,715	6,866 Added 80.61%	15,384 $786,000
Q4 2019 Jan 28, 2020	BUY	$45.7 - $81.86 $271,869 - $486,985	5,949 Added 231.57%	8,518 $677,000
Q3 2019 Nov 04, 2019	BUY	$45.35 - $57.91 $116,504 - $148,770	2,569 New	2,569 $125,000
Q2 2019 Jul 29, 2019	SELL	$52.6 - $63.29 $256,109 - $308,159	-4,869 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$39.99 - $53.48 $255,376 - $341,523	-6,386 Reduced 56.74%	4,869 $258,000
Q4 2018 Feb 01, 2019	BUY	$31.54 - $46.67 $354,982 - $525,270	11,255 New	11,255 $462,000
Q3 2018 Nov 06, 2018	SELL	$38.0 - $51.1 $127,566 - $171,542	-3,357 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$38.7 - $50.15 $6,888 - $8,926	-178 Reduced 5.04%	3,357 $152,000
Q1 2018 May 03, 2018	SELL	$39.6 - $65.9 $48,232 - $80,266	-1,218 Reduced 25.63%	3,535 $171,000
Q4 2017 Jan 24, 2018	SELL	$29.7 - $45.7 $131,897 - $202,953	-4,441 Reduced 48.3%	4,753 $187,000
Q3 2017 Nov 07, 2017	BUY	$25.1 - $31.05 $230,769 - $285,473	9,194	9,194 $285,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account